Xiaoling Wan

机构：Shanghai Jiao Tong University, Xianning Central Hospital, Shanghai First People's Hospital, Center for High Pressure Science & Technology Advanced Research · ORCID：0000-0003-4583-8686

发表论文 74 篇 · 总被引 1089 次 · h-index 19

代表论文

• AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa (2023 · Nature Communications · 被引 56)
• Macrophage Sult2b1 promotes pathological neovascularization in age-related macular degeneration (2023 · Life Science Alliance · 被引 17)
• SYVN1 Promotes STAT3 Protein Ubiquitination and Exerts Antiangiogenesis Effects in Retinopathy of Prematurity Development (2023 · Investigative Ophthalmology & Visual Science · 被引 17)
• Bifidobacterium promotes retinal ganglion cell survival by regulating the balance of retinal glial cells (2023 · CNS Neuroscience & Therapeutics · 被引 14)
• AIM2 activation mediated by RIPK1/3-dependent mitochondrial DNA release drives Aβ1−40-Induced retinal pigment epithelium injury (2025 · Cell Communication and Signaling · 被引 7)
• circSIRT2 / miR ‐542‐3p/ VASH1 axis regulates endothelial‐to‐mesenchymal transition ( EndMT ) in subretinal fibrosis in age‐related macular degeneration models (2025 · Aging Cell · 被引 7)